Compounds according to Formula I are potent inhibitors of Arginase I and II activity:where R1, R2, R3, R4, D, W, X, Y, and Z are defined in the specification. The invention also provides pharmaceutical compositions of the compounds and said compounds for use in treating or preventing cancer or a disease or a condition associated with expression or activity of arginase I, arginase II or a combination thereof.